25
Grown Up Congenital Heart (disease)

G rown U p C ongenital H eart (disease)

  • Upload
    africa

  • View
    33

  • Download
    2

Embed Size (px)

DESCRIPTION

G rown U p C ongenital H eart (disease). 1965. 1500.000. ↑ 5% anno. 1250.000. 1000.000. 750.000. 500.000. 250.000. 1970. 1980. 1990. 2000. 2010. JACC 2001 Warnes JACC 2006 Williams. 2005. %. RVEF. Millane JACC 2000. Vander Velde Eur J Epidemiol 2005. - PowerPoint PPT Presentation

Citation preview

Page 1: G rown U p C ongenital    H eart (disease)

Grown

Up

Congenital

Heart (disease)

Page 2: G rown U p C ongenital    H eart (disease)

70

30

Ad. Pat Ped. Pat

1965

Page 3: G rown U p C ongenital    H eart (disease)

250.000

500.000

750.000

1000.000

1500.000

1970 1980 1990 2000 2010

1250.000

↑ 5% anno

JACC 2001 Warnes JACC 2006 Williams

Page 4: G rown U p C ongenital    H eart (disease)

40

60

Ad. Pat Ped. Pat

2005

Page 5: G rown U p C ongenital    H eart (disease)
Page 6: G rown U p C ongenital    H eart (disease)

0

10

20

30

40

50

60

70

8 10 12 14 16 18 20 22 24 26 ys

%RVEF

Millane JACC 2000

Page 7: G rown U p C ongenital    H eart (disease)

Vander Velde Eur J Epidemiol 2005

Page 8: G rown U p C ongenital    H eart (disease)

ACE/ARB treatment

Ramipril … 17 pts Therrien InT J Card 08

Losartan .. 37 pts Dore Circ 2005

Enalapril …. 9 pts Robinson Ped Card 2002

Losartan … 7 pts Lester AmJ C 2001

Enalapril ….. 14 pts Hecther AmJC 2001

No high-quality data support the use

Beta/Blocker treatment

…..31 pts Doughan Am J Card 2007

…. 14 pts Bouallal Card Young 2010

… 8 pts Josephson Can J Card 2006

It is difficult to conclude that B/blockade is beneficial

Page 9: G rown U p C ongenital    H eart (disease)

Type of procedure at risk

Cardiac conditions at highest risk

Page 10: G rown U p C ongenital    H eart (disease)

0

2

4

6

8

10

12

14

16

18

20

SVT VT Endocardits CVA

%

Engelfriet Eur H J 2005

Page 11: G rown U p C ongenital    H eart (disease)

The principal reasons for 373 medical admissions to the Royal Brompton Hospital GUCH unit in 1997.

Sommerville Heart 2002

Page 12: G rown U p C ongenital    H eart (disease)

0

5

10

15

20

25

30

35

40

Arr Ac HF Inf Sync TE Chestpain

Hem Ao An Card Arr Oth

%

Kaemmerer Am JC 2008

Page 13: G rown U p C ongenital    H eart (disease)

The updated recommendations dramatically change long established practice for primary care physicians,cardiologists, dentists, and their patients. For ethical reasons, these practitioners need to discuss the potential benefit and harm of antibiotic prophylaxis with their patients before a final decision is made. Following informed review and discussion, some patients (and also physicians) may wish to continue with routine prophylaxis in the individual case, and these views should be respected.

Page 14: G rown U p C ongenital    H eart (disease)

Br Med Bull. 2008;85:151-80.Adult congenital heart disease: a 2008 overview.

Bédard E, Shore DF, Gatzoulis MA.

SourceAdult Congenital Heart Center and Center for Pulmonary Arterial

Hypertension, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK

Current ACC/AHA GL are much more restrictive concernig the use of prophylactic antibiotics. However , we advocate a prudent approach for endocarditis prohylaxis in patients with CHD

Page 15: G rown U p C ongenital    H eart (disease)

Good oral hygiene and regular dental review have an essential role inreducing the risk of IE.

Transient bacteraemia occurs frequently in the context of these daily routine activities

It appears plausible that a large proportion of IE-causing bacteraemia may derive from daily routine activities such as tooth brushing, flossing….

In the majority of patients, no potential index procedure preceding the first clinical appearance of IE can be identified

Page 16: G rown U p C ongenital    H eart (disease)

Atrial septal defect

Interventional options:surgery or device closure

Unresolved issues:surgery vs device closure

Page 17: G rown U p C ongenital    H eart (disease)

0

5

10

15

20

25

30

< 20 21-30 31-40 41-50 51-60 61-70 > 70 ys

Mayo

Toronto

%

JACC 2001 Warnes

Page 18: G rown U p C ongenital    H eart (disease)

0

5

10

15

20

25

30

35

40

ASD VSD ToF CoAo TGA Marfan Fontan Cyan. Def

Engelfriet Eur H J 2005

Y

21

79

> 50 y < 50 y

Page 19: G rown U p C ongenital    H eart (disease)

Ebstein’s anomaly RV to PA conduits

Page 20: G rown U p C ongenital    H eart (disease)

0

5

10

15

20

25

30

35

40

45

50

Normali

NormaliNYHA I

NYHA IINYHA III

NYHA I

NYHA II

NYHA III

GUCH età media 33 y

Pazienti HF età media 59 y

VO2 ml/kg/m

…….all should have a measurement of exercise physiology.all should have a measurement of exercise physiology

Diller Circulation 2005

Page 21: G rown U p C ongenital    H eart (disease)

65% 18%

17%

Non cardiac Peri op CV

Am J Cardiol 2000 Oechslin

Analyzing the mortality causes in Analyzing the mortality causes in GUCH pts it appears that GUCH pts it appears that cardiovascular death is the most cardiovascular death is the most frequent: 65% of all deaths, excluding frequent: 65% of all deaths, excluding the perioperative cardiac surgery the perioperative cardiac surgery deaths. deaths.

26%

21%18%

18%

17%

Non cardiac Peri op Other CV HF SD

The most common mode is SD, followed The most common mode is SD, followed

by progressive HFby progressive HF

Page 22: G rown U p C ongenital    H eart (disease)

ICD therapy in adult patients with ToFWitte Europace 2008

...inappropriate anti-tachycardia pacing delivery (20%) and inappropriate cardioversion (25 %) ...Conclusion :Tetralogy of Fallot patients have a higher risk of inappropriate therapies …..

ICD in Tetralogy of Fallot Khairy Circ 2008

36 patients (29.8%) experiencedcomplications, of which 6 (5.0%) were acute, 25 (20.7%) were late lead-related, and 7 (5.8%) were late generator-related complications. Conclusions:…late lead-related complications are common.

14 patients (37.8%) experienced complications: 5 (13.5%) acute, 1 (2.7%) late generator related, and 12 (32.4%) late lead related.

SD and ICD in TGA With Intra-atrial Baffles: A Multicenter Study Khairy Circ Arr 2008

Specific criteria for ICD implantation for primary prevention have not been well defined yet

Page 23: G rown U p C ongenital    H eart (disease)

GUCHGUCHCardiologo pediatra

Cardiologo dell’adulto

Page 24: G rown U p C ongenital    H eart (disease)

RETE INTERAZIENDALE per la GESTIONE dei GUCH

ICLAS

IGG

ASl 3GUCHCardiologo Pediatra Cardiologo dell’Adulto

Ambulatorio per i GUCH ASL 3 - Nervi

Page 25: G rown U p C ongenital    H eart (disease)

RETE INTERAZIENDALE per la GESTIONE dei GUCH

ICLAS

IGG

ASl 3

GUCHCardiologo Pediatra Cardiologo dell’Adulto

Ambulatorio per i GUCH ASL 3 - Nervi